Search research articles
Contact Us
Filters
Showing results (491-500 of 869) with videos related to
Page
of 87
Sort By:
Blood
|
March 16, 2025
Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple Myeloma
Chandraditya Chakraborty, Srikanth Talluri, Moritz Binder, et al.
British Journal of Haematology
|
January 21, 2016
Clinical utility of C-terminal telopeptide of type 1 collagen in multiple myeloma
Kay R Ting, Jennifer J Brady, Abdul Hameed, et al.
Cancer Research Communications
|
September 8, 2023
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
Jiahui Liu, Wenqiang Yan, Huishou Fan, et al.
Blood
|
June 21, 2003
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma
Laurence Catley, Ellen Weisberg, Yu-Tzu Tai, et al.
British Journal of Haematology
|
July 19, 2006
Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib
Reshma Shringarpure, Laurence Catley, Deepak Bhole, et al.
Leukemia
|
July 8, 2020
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
Liang Lin, Shih-Feng Cho, Lijie Xing, et al.
Blood
|
July 10, 2009
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance
Simona Blotta, Pierfrancesco Tassone, Rao H Prabhala, et al.
The Journal of Biological Chemistry
|
December 17, 2002
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells
Klaus Podar, Yu-Tzu Tai, Craig E Cole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma
Mariateresa Fulciniti, Teru Hideshima, Claudine Vermot-Desroches, et al.
Blood
|
October 27, 2023
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma
Jooeun Bae, Shuichi Kitayama, Zach Herbert, et al.
Page
of 87
Search research articles
Search
Showing results (491-500 of 869) with videos related to
Sort By:
Page
of 87
Blood
|
March 16, 2025
Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple Myeloma
Chandraditya Chakraborty, Srikanth Talluri, Moritz Binder, et al.
British Journal of Haematology
|
January 21, 2016
Clinical utility of C-terminal telopeptide of type 1 collagen in multiple myeloma
Kay R Ting, Jennifer J Brady, Abdul Hameed, et al.
Cancer Research Communications
|
September 8, 2023
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
Jiahui Liu, Wenqiang Yan, Huishou Fan, et al.
Blood
|
June 21, 2003
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma
Laurence Catley, Ellen Weisberg, Yu-Tzu Tai, et al.
British Journal of Haematology
|
July 19, 2006
Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib
Reshma Shringarpure, Laurence Catley, Deepak Bhole, et al.
Leukemia
|
July 8, 2020
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
Liang Lin, Shih-Feng Cho, Lijie Xing, et al.
Blood
|
July 10, 2009
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance
Simona Blotta, Pierfrancesco Tassone, Rao H Prabhala, et al.
The Journal of Biological Chemistry
|
December 17, 2002
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells
Klaus Podar, Yu-Tzu Tai, Craig E Cole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma
Mariateresa Fulciniti, Teru Hideshima, Claudine Vermot-Desroches, et al.
Blood
|
October 27, 2023
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma
Jooeun Bae, Shuichi Kitayama, Zach Herbert, et al.
Page
of 87